Vivani Medical (NASDAQ:VANI – Get Free Report) issued its earnings results on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Price Performance
Vivani Medical stock opened at $1.11 on Monday. The business has a fifty day moving average price of $1.14 and a 200-day moving average price of $1.21. The firm has a market capitalization of $65.75 million, a P/E ratio of -2.47 and a beta of 3.20. Vivani Medical has a one year low of $1.03 and a one year high of $2.22.
Analysts Set New Price Targets
Separately, HC Wainwright reissued a “buy” rating and issued a $4.00 price objective on shares of Vivani Medical in a report on Wednesday, March 26th.
About Vivani Medical
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Articles
- Five stocks we like better than Vivani Medical
- Where Do I Find 52-Week Highs and Lows?
- Netflix Poised for Significant Rally as a Safe Haven Stock
- How to Invest in Insurance Companies: A Guide
- Lululemon Pulls Back Into Classic Dip-Buying Opportunity
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Cintas Delivers Earnings Beat, Signals More Growth Ahead
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
